Dashboard
Manage Tickers

BNTC


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
11/06/2025 17:05:48

benitec-biopharma-prices-100m-offering-including-593m-common-shares-and-concurrent-148m-share-direct-offering-at-1350-each
Benitec Biopharma Prices $100M Offering In...
11/06/2025 07:35:45

benitec-biopharma-announces-underwritten-common-stock-offering-terms-not-disclosed
Benitec Biopharma Announces Underwritten C...
11/05/2025 21:44:29

Benitec Biopharma Inc. (NASDAQ:BNTC) ("Benitec" or the "Company"), a clinical-stage, gene therapy-focused, biot...

hc-wainwright--co-maintains-buy-on-benitec-biopharma-raises-price-target-to-35
HC Wainwright & Co. Maintains Buy on Benit...
11/04/2025 17:30:57

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Benitec Biopharma (NASDAQ:BNTC) with a Buy and raises the price...

citizens-maintains-market-outperform-on-benitec-biopharma-raises-price-target-to-22
Citizens Maintains Market Outperform on Be...
11/04/2025 12:34:08

Citizens analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the price tar...

benitec-biopharma-plans-to-meet-with-fda-in-2026-to-confirm-bb-301-pivotal-study-design
Benitec Biopharma Plans To Meet With FDA I...
11/03/2025 12:14:21

benitec-biopharma-provides-interim-clinical-results-for-bb-301-phase-1b2a-clinical-trial-following-administration-of-bb-301-cohort-1-patients-showed-significant-sustained-improvements-across-multiple-clinical-measures
Benitec Biopharma Provides Interim Clinica...
11/03/2025 12:13:37

Benitec Biopharma Inc. (NASDAQ:BNTC) ("Benitec" or "Company"), a clinical-stage, gene therapy-focused, biotechn...

reported-sunday-benitec-biopharma-announces-upcoming-phase-1b2a-bb-301-clinical-study-update-for-oculopharyngeal-muscular-dystrophy-patients-in-november-3-2025-webcast
Reported Sunday, Benitec Biopharma Announc...
11/03/2025 07:45:48

jmp-securities-reiterates-market-outperform-on-benitec-biopharma-maintains-20-price-target
JMP Securities Reiterates Market Outperfor...
09/24/2025 13:02:39

JMP Securities analyst Silvan Tuerkcan reiterates Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and maintains $20...

benitec-biopharma-files-for-mixed-shelf-offering-of-up-to-200m
Benitec Biopharma Files For Mixed Shelf Of...
09/22/2025 21:27:18

-SEC Filing

correction-benitec-biopharma-q4-eps-042-misses-033-estimate
CORRECTION: Benitec Biopharma Q4 EPS $(0.4...
09/22/2025 21:12:13

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $...

oppenheimer-maintains-outperform-on-benitec-biopharma-lowers-price-target-to-29
Oppenheimer Maintains Outperform on Benite...
09/16/2025 15:56:21

Oppenheimer analyst Andreas Argyrides maintains Benitec Biopharma (NASDAQ:BNTC) with a Outperform and lowers the price targe...

benitec-biopharma-receives-green-light-to-advance-bb-301-trial-after-safety-review-cohort-2-enrollment-set-for-q4-2025
Benitec Biopharma Receives Green Light To ...
07/09/2025 12:18:04

-In April 2025 the Sixth and Final Subject of Cohort 1 was Safely Treated with the Low Dose of BB-301 in the Phase 1b/2a Clinic...

hc-wainwright--co-reiterates-buy-on-benitec-biopharma-maintains-28-price-target
HC Wainwright & Co. Reiterates Buy on Beni...
05/19/2025 11:15:14

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Benitec Biopharma (NASDAQ:BNTC) with a Buy and maintains $28 p...

jmp-securities-reiterates-market-outperform-on-benitec-biopharma-maintains-20-price-target
JMP Securities Reiterates Market Outperfor...
05/15/2025 13:45:53

JMP Securities analyst Silvan Tuerkcan reiterates Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and maintains $20...

benitec-biopharma-q3-eps-024-beats-035-estimate
Benitec Biopharma Q3 EPS $(0.24) Beats $(0...
05/14/2025 12:13:51

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0...

jmp-securities-maintains-market-outperform-on-benitec-biopharma-raises-price-target-to-20
JMP Securities Maintains Market Outperform...
04/10/2025 13:18:43

JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the pri...

hc-wainwright--co-reiterates-buy-on-benitec-biopharma-maintains-28-price-target
HC Wainwright & Co. Reiterates Buy on Beni...
03/24/2025 11:01:18

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Benitec Biopharma (NASDAQ:BNTC) with a Buy and maintains $28 p...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
03/21/2025 12:10:22

benitec-biopharma-reports-interim-clinical-results-for-three-subjects-treated-with-bb-301-in-phase-1b2a-study
Benitec Biopharma Reports Interim Clinical...
03/19/2025 11:12:34

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION